First Manhattan CO Immuno Gen, Inc. Transaction History

First Manhattan CO

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	SELL	$12.46 - $29.95 $3.44 Million - $8.26 Million	-275,900 Reduced 97.35%	7,500 $222,000
Q3 2023 Nov 14, 2023	SELL	$14.09 - $19.87 $20.1 Million - $28.3 Million	-1,424,100 Reduced 83.4%	283,400 $4.5 Million
Q2 2023 Aug 14, 2023	BUY	$3.75 - $20.05 $6.38 Million - $34.1 Million	1,700,000 Added 22666.67%	1,707,500 $32.2 Million
Q1 2022 May 16, 2022	SELL	$4.26 - $7.48 $4.06 Million - $7.12 Million	-951,932 Reduced 99.22%	7,500 $35,000
Q4 2021 Feb 14, 2022	BUY	$4.75 - $7.5 $4.52 Million - $7.14 Million	951,886 Added 12614.44%	959,432 $7.12 Million
Q4 2020 Feb 16, 2021	SELL	$3.7 - $7.66 $162 - $337	-44 Reduced 0.58%	7,546 $48,000
Q3 2020 Nov 12, 2020	BUY	$3.45 - $4.89 $151 - $215	44 Added 0.58%	7,590 $27,000
Q2 2019 Aug 16, 2019	SELL	$1.8 - $3.3 $2,700 - $4,950	-1,500 Reduced 16.58%	7,546 $16,000
Q4 2018 Jan 30, 2019	BUY	$3.94 - $9.7 $5,910 - $14,549	1,500 Added 19.88%	9,046 $43,000
Q3 2018 Oct 15, 2018	BUY	$8.6 - $11.26 $38,700 - $50,670	4,500 Added 147.73%	7,546 $71,000
Q1 2018 Apr 20, 2018	SELL	$6.7 - $12.95 $2,351 - $4,545	-351 Reduced 10.33%	3,046 $32,000
Q4 2017 Jan 22, 2018	BUY	$5.07 - $7.92 $1,779 - $2,779	351 Added 11.52%	3,397 $21,000
Q3 2017 Oct 25, 2017	BUY	$5.4 - $8.47 $16,448 - $25,799	3,046	3,046 $23,000

1.41M

Ticker IMGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 220,712,992
Description
ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sun...

Get notified when there are updates to the investment portfolio of First Manhattan CO, based on Form 13F filings with the SEC.

Stay updated on First Manhattan CO with notifications on news.